ARGENX SE is 17.6x more valuable than Beam Therapeutics Inc. by market capitalization ($53.35 B vs $3.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BEAM | ARGX |
|---|---|---|
| Market cap | $3.03 B | $53.35 B |
| US-listed rank | #1789 | #306 |
| Revenue (latest FY) | $139.74M | - |
| Net income (latest FY) | -$79.99M | - |
| Net margin | -57.2% | - |
| SEC filings | 488 | 272 |
ARGENX SE is 17.6x more valuable than Beam Therapeutics Inc. by market capitalization ($53.35 B vs $3.03 B).
Full pages: Beam Therapeutics Inc. and ARGENX SE, or browse the full rankings.